Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKrm22 Plc Regulatory News (KRM)

Share Price Information for Krm22 Plc (KRM)

Share Price is delayed by 15 minutes
Get Live Data
32.50    0.00 (0.00%)
Bid:
32.00
Ask:
33.00
Spread: 1.00 (3.125%)
Market Cap: £19.28m
KRM Live PriceLast checked at - London Stock Exchange

Intraday Krm22 Plc Share Chart

Trading Update

29 Jan 2026 07:00

RNS Number : 8134Q
KRM22 PLC
29 January 2026
 

KRM22 plc

("KRM22", the "Group" or the "Company")

Trading Update

 

KRM22 plc, (AIM: KRM) the technology and software investment company, with a particular focus on risk management in capital markets, today issues the following trading update for the 12-month period ended 31 December 2025 ("FY2025").

 

The Company expects to report audited results for FY2025 in May 2026, and is pleased to report the following financial highlights*:

 

· ARR at 31 December 2025 of £7.6m (FY2024: £6.6m, £6.4m at constant FX rates) - growth of 19% at constant FX rates

New contracted ARR in the year of £1.6m (FY2024: £1.7m)

· Total revenue recognised of approximately £7.5m (FY2024: £6.8m) - growth of 11%

· Adjusted EBITDA: £0.7m (FY2024: £1.0m)

· Gross cash as of 31 December 2025 of £5.2m with net cash of £5.2m (FY2024: gross cash of £1.0m, net debt of £3.5m)

· Successful £9.2m fundraise completed in November 2025

 

As reported in the trading update on 7th August 2025, approximately 50% of Group ARR is derived from USD denominated contracts and, with a 7 per cent change in GBP:USD FX rates in FY2025, ARR at the start of FY2025 restated using a constant FX rate as at the end of FY2025 was £6.4m (£6.6m as previously reported using 31 December 2024 FX rates). 

 

Using constant exchange rates, the change in ARR during FY2025 was a net increase of £1.2m. This was driven by £1.6m from cross-sales to existing customers and contractual price increases. Specifically, cross-sales of the Risk Manager, Limits Manager, and Market Surveillance applications generated £1.1m, while contractual price increases across the same applications added another £0.5m. This growth was partially offset by a churn of £0.4m, which was mainly attributed to two institutional customers who cancelled their license of the Market Surveillance application whilst, in both cases, singing new multi-year contracts to license other KRM22 applications.

 

With the successful fundraise completed in November 2025 raising £9.2m, KRM22 is now debt free and, following receipt of a three-year license fee payment from one its customers, the Company had a strong cash position at 31 December 2025 of £5.2m. This cash will be utilised to support the growth strategy presented to investors, namely investment in additional sales, marketing and development resource to allow KRM22 to expand its existing suite of risk management applications to offer multi-asset solutions to the capital markets industry. Importantly, post the fund raising, management is able to focus on growing the business and delivering on the Company's strategy, without the distraction of managing a complex balance sheet and operating within restrictive financial covenants.

 

Dan Carter, CEO commented: "KRM22 delivered a solid performance in 2025, with ARR growing 19% to £7.6m with new contracted ARR of £1.6m reflecting the continued demand for our applications. With our year‑end cash position strengthened significantly to £5.2m, we enter 2026 with a strong sales pipeline, a robust balance sheet, and clear strategic priorities, positioning the business for continued growth."

 

\* The financial expectations noted above are preliminary, and subject to year-end financial close and audit review processes.

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

For further information please contact:

 

KRM22 plc

Dan Carter, CEO

Kim Suter, CFO

 

InvestorRelations@krm22.com

Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)

Stephen Keys / Isaac Hooper (Corporate Finance)

Sunila de Silva (ECM)

 

+44 (0)20 7220 0500

 

 

 

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018. The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.

 

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management. The Global Risk Platform provides applications to help address firms' trading and corporate risk challenges and to manage their entire enterprise risk profile.

 

Capital markets companies' partner with KRM22 to optimise risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.

 

KRM22 plc is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

 

See more about KRM22 at KRM22.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEWEFAEMSESF
Date   Source Headline
26th May 20263:24 pmRNSHolding(s) in Company
26th May 20262:25 pmRNSHolding(s) in Company
22nd May 20267:00 amRNSDirector Dealings
20th May 202611:19 amRNSDirector Dealings
20th May 20267:00 amRNSNotice of AGM and Posting of Annual Report
13th May 20267:00 amRNSFinal Results
29th Jan 20267:00 amRNSTrading Update
7th Jan 20267:00 amRNSAppointment of Director
20th Nov 20254:12 pmRNSTR-1
11th Nov 20257:00 amRNSIssue of Equity
10th Nov 20259:28 amRNSHolding(s) in Company
5th Nov 20251:05 pmRNSResult of GM
15th Oct 20257:00 amRNSResult of Placing
14th Oct 20254:50 pmRNSProposed Placing and Subscription
17th Sep 20257:00 amRNSInterim Results
7th Aug 20257:00 amRNSTrading Update
21st Jul 20257:00 amRNSIssue of Equity
27th Jun 20252:10 pmRNSResult of AGM
6th Jun 20257:00 amRNSDirector Dealing
2nd Jun 20257:00 amRNSIssue of Restricted Stock Units
30th May 20257:00 amRNSNotice of AGM and Posting of Annual Report
21st May 20257:00 amRNSDirector Dealing
19th May 20257:00 amRNSFinal Results
29th Apr 20257:00 amRNSFacility Amendment
7th Apr 20257:00 amRNSNew Customer Contracts
1st Apr 20257:00 amRNSFacility Amendment
18th Mar 20257:00 amRNSIssue of Equity
4th Mar 20257:00 amRNSNew Customer Contract
13th Feb 20255:00 pmRNSDirector Dealing
22nd Jan 20257:00 amRNSTrading Update
10th Jan 20257:00 amRNSIssue of Equity
23rd Dec 20247:00 amRNSLoan Facility Amendment
15th Oct 20247:00 amRNSIssue of Equity
25th Sep 20247:00 amRNSInterim Results
3rd Sep 20247:00 amRNSChange of Registered Office
29th Aug 20247:00 amRNSNew Customer Contract
22nd Aug 202410:00 amRNSGrant of Options and Director/PDMR Shareholding
19th Aug 20247:00 amRNSIssue of Equity
18th Jul 20247:00 amRNSHalf Year Trading Update
21st Jun 202412:49 pmRNSResult of AGM
29th May 20247:00 amRNSNotice of AGM and Posting of Annual Report
22nd May 20247:00 amRNSFinal Results
16th Apr 20247:00 amRNSDirector Dealings
15th Apr 20247:00 amRNSNew Customer Contract
10th Apr 20247:00 amRNSIssue of Equity
7th Mar 20247:00 amRNSBoard Changes
21st Feb 20247:00 amRNSTrading Update
1st Dec 20237:00 amRNSIssue of Restricted Stock Units
26th Sep 20237:00 amRNSInterim Results
27th Jul 202311:48 amRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.